Press release

SynBioBeta, the leading community of entrepreneurs, investors, innovators, and biological engineers, today announced details for its flagship SynBioBeta 2024 conference. The premier annual event for the synthetic biology industry will be held May 6-9, 2024, in San Jose, gathering an estimated 2,000 attendees from around the world. "Synthetic biology is rapidly transforming nearly every sector...

As the conference season kicks off, VC investors are gearing up for a cautiously optimistic 2024, where the normalization of valuations stands out as a positive trend. However, a growing concern shows over the potential impact of geopolitical conflicts and climate change pressures on this year's performance. These critical topics are poised to take center...

Following the resounding success of the Longevity Investors Lunch held during the World Economic Forum in Davos in January, Longevity Investors is thrilled to unveil the upcoming Longevity Investors Conference 2024. Set against the picturesque backdrop of Gstaad, Switzerland, the conference is scheduled to take place from September 24th to 27th at the esteemed 5-star...

NEW YORK, April 3, 2024 – In a groundbreaking announcement set to impact the future of longevity research and outreach, two historic longevity nonprofits - SENS Research Foundation and Lifespan.io (Lifespan Extension Advocacy Foundation) - have unveiled plans to merge, upon completion of regulatory approvals. Lifespan.io, renowned for its unwavering advocacy for longevity and responsible...

Hevolution announced its investment of $20 million (SAR 75,000,000) as the lead investor for a $50 million (SAR 188,000,000) Series A financing extension in Aeovian Pharmaceuticals. Hevolution’s investment will advance promising therapies that target the mTORC1 biological pathway, helping find solutions to major unmet medical needs including neurological diseases and other diseases of aging. Hevolution’s...

According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest...